CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	May 31, 2012	May 31, 2011	May 31, 2012	May 31, 2011
Revenue	$ 12,330	$ 12,330	$ 24,659	$ 24,659
Operating expenses
Selling, general and administrative	143,035	173,648	368,047	358,769
Research and development	212,398	147,394	272,084	236,442
Stock-based compensation	107,544	534,428	120,716	650,928
Depreciation	0	475	0	950
Total operating expenses	462,977	855,945	760,847	1,247,089
Loss from operations	(450,647)	(843,615)	(736,188)	(1,222,430)
Other income (expense)
Grant revenue	0	104,662	0	229,387
Interest expense	(812)	(5,951)	(6,662)	(11,853)
Change in fair value of derivative liability	42,737	(476,396)	43,964	(557,320)
Interest income	213	410	487	860
Total other income (expense)	42,138	(377,275)	37,789	(338,926)
Net loss	(408,509)	(1,220,890)	(698,399)	(1,561,356)
Less net loss attributable to the noncontrolling interests	(29,750)	(47,720)	(49,070)	(70,130)
Net loss attributable to MultiCell Technologies, Inc.	$ (378,759)	$ (1,173,170)	$ (649,329)	$ (1,491,226)
Basic and Diluted Loss Per Common Share (in dollars per share)	$ (0.0004)	$ (0.0018)	$ (0.0007)	$ (0.0025)
Basic and Diluted Weighted-Average Common Shares Outstanding (in shares)	942,621,233	639,938,822	903,297,226	600,168,478